SCHEMBL1023945

SCHEMBL1023945

CCCCCCCCCCCC[Sn](CCCCCCCC)(CCCCCCCC)CCCCCCCCCCCC

nearest known ligand 0.57

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.57
THRB P10828 1/20 0.57
DNM1 Q05193 7/20 0.42
ALDH1A1 P00352 3/20 0.42
LMNA P02545 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
HSD17B10 Q99714 1/20 0.42
SLC22A1 O15245 1/20 0.42
EPHX1 P07099 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL333362 1.00 TSHR (0.57) TSHRTHRBDNM1ALDH1A1LMNA
SCHEMBL1028561 1.00 TSHR (0.57) TSHRTHRBDNM1ALDH1A1LMNA
SCHEMBL2554244 1.00 TSHR (0.57) TSHRTHRBDNM1ALDH1A1LMNA
SCHEMBL1032318 1.00 TSHR (0.57) TSHRTHRBDNM1ALDH1A1LMNA
SCHEMBL1030426 1.00 TSHR (0.57) TSHRTHRBDNM1ALDH1A1LMNA
SCHEMBL26982433 1.00 TSHR (0.57) TSHRTHRBDNM1ALDH1A1LMNA
SCHEMBL11334517 0.97 TSHR (0.53) TSHRTHRBDNM1ALDH1A1LMNA
SCHEMBL27560943 0.97 TSHR (0.53) TSHRTHRBDNM1ALDH1A1LMNA
SCHEMBL15529318 0.97 TSHR (0.53) TSHRTHRBDNM1ALDH1A1LMNA
SCHEMBL9757543 0.97 TSHR (0.53) TSHRTHRBDNM1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 215 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180312623-A1 Polyurethane Elastomer with High Ultimate Elongation WANG LIANG (US) 2018-11-01 US claimed
US-9879153-B2 Anti-icing composite WANG LIANG (US) 2018-01-30 US claimed
US-20160009971-A1 Anti-Icing Composite WANG LIANG (US) 2016-01-14 US claimed
US-6809135-B2 ORGANO-TIN, ORGANO- TITANIUM, AND/OR ORGANO-ZIRCONIUM ADDITIVE THE GOODYEAR TIRE & RUBBER COMPANY 2004-10-26 US claimed
US-20020010258-A1 Silica reinforced rubber composition and article with component thereof, including tires GOODYEAR TIRE & RUBBER COMPANY, THE 2002-01-24 US claimed
US-6313220-B1 BLENDING IN ORGANIC SOLVENT SOLUTION OF ELASTOMER HOST, TELECHELIC HYDROXY AND/OR ALKOXY TERMINATED POLYSILOXANE, RETICULATING AGENT HAVING A MOIETY WHICH COMPRISES AT LEAST TWO ALKOXY GROUPS, CATALYST; RECOVERING COMPOSITE GOODYEAR TIRE & RUBBER COMPANY, THE 2001-11-06 US claimed
EP-1148091-A2 Silica reinforced rubber composition and article with component thereof, including tires THE GOODYEAR TIRE & RUBBER COMPANY (US) 2001-10-24 EP claimed
EP-1130053-A2 Preparation of reinforced elastomer, elastomer composite and tire having component thereof THE GOODYEAR TIRE & RUBBER COMPANY (US) 2001-09-05 EP claimed
US-20260146014-A1 METHODS FOR PRODUCING PHENOLIC COMPOUNDS INCLUDING SYRINGOL FROM BIOMASS AND USING SAME FOR 3D PRINTING ALIGN TECHNOLOGY, INC. (US) 2026-05-28 US disclosed
US-12630734-B2 Weak covalent crosslinks in thermoset materials for increased toughness ALIGN TECHNOLOGY, INC. (US) 2026-05-19 US disclosed
US-20260125496-A1 MONOMERS AND CURABLE COMPOSITIONS FOR CRYSTALLINITY CONTROL IN POLYMERIC MATERIALS FOR 3D-PRINTED DENTAL DEVICES ALIGN TECHNOLOGY INC (US) 2026-05-07 US disclosed
EP-4704757-A1 SEMICRYSTALLINE SULFUR CONTAINING POLYMERS FOR ORTHODONTIC APPLICATIONS Align Technology, Inc. (US) 2026-03-11 EP disclosed
US-20260028489-A1 SUPPORTED POLYMERIZATION INHIBITORS AND THEIR USE IN CURABLE COMPOSITIONS FOR 3D PRINTING ALIGN TECHNOLOGY INC (US) 2026-01-29 US disclosed
US-20260015450-A1 ADDITIVE MANUFACTURING USING VARIABLE TEMPERATURE-CONTROLLED RESINS ALIGN TECHNOLOGY INC (US) 2026-01-15 US disclosed
EP-1130053-A2 Preparation of reinforced elastomer, elastomer composite and tire having component thereof THE GOODYEAR TIRE & RUBBER COMPANY (US) 2001-09-05 EP disclosed
US-6139613-A Multilayer pigments and their manufacture AVEKA, INC. (US) 2000-10-31 US disclosed
EP-1017746-A1 HYDROPHILIC MATERIALS AND THEIR METHOD OF PREPARATION SUNSMART, INC. (US) 2000-07-12 EP disclosed
US-6045650-A A LIQUID COATING OF AN OXIDIZABLE MATERIAL CONTAINING AT LEAST ONE ELEMENT OTHER THAN CARBON, HYDROGEN, OXYGEN AND NITROGEN IS APPLIED ONTO THE SURFACE OF A SUBSTRATE, OXIDIZING THE OXIDIZABLE MATERIAL TO FORM AN OXIDE COATING SUNSMART, INC. (US) 2000-04-04 US disclosed
US-5962082-A Process for applying liquid coatings to solid particulate substrates AVEKA, INC. (US) 1999-10-05 US disclosed
WO-1999014276-A1 HYDROPHILIC MATERIALS AND THEIR METHOD OF PREPARATION SUNSMART, INC. (US) 1999-03-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12630734-B2 Weak covalent crosslinks in thermoset materials for increased toughness MACF1, SMCHD1, SMC4 TSHR 3278/4885THRB 3366/4885DNM1 3125/4885
US-20260146014-A1 METHODS FOR PRODUCING PHENOLIC COMPOUNDS INCLUDING SYRINGOL FROM BIOMASS AND USING SAME FOR 3D PRINTING VCL, HTR3D, COL1A1 TSHR 4529/4885THRB 2975/4885DNM1 859/4885
US-20260015450-A1 ADDITIVE MANUFACTURING USING VARIABLE TEMPERATURE-CONTROLLED RESINS HTR3D, PF4, PRPF19 TSHR 2867/4885THRB 2558/4885DNM1 4381/4885
US-20260028489-A1 SUPPORTED POLYMERIZATION INHIBITORS AND THEIR USE IN CURABLE COMPOSITIONS FOR 3D PRINTING ILK, MTCL3, MARK3 TSHR 2217/4885THRB 2280/4885DNM1 1161/4885
US-20260125496-A1 MONOMERS AND CURABLE COMPOSITIONS FOR CRYSTALLINITY CONTROL IN POLYMERIC MATERIALS FOR 3D-PRINTED DENTAL DEVICES SMCHD1, SMC4, SMC3 TSHR 2031/4885THRB 1241/4885DNM1 1891/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.